Surgical trauma induces postoperative T-cell dysfunction in lung cancer patients through the programmed death-1 pathway
- 482 Downloads
The programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) pathway have been shown to be involved in tumor-induced and sepsis-induced immunosuppression. However, whether this pathway is involved in the surgery-induced dysfunction of T lymphocytes is not known. Here, we analyzed expression of PD-1 and PD-L1 on human peripheral mononuclear cells during the perioperative period. We found that surgery increased PD-1/PD-L1 expression on immune cells, which was correlated with the severity of surgical trauma. The count of T lymphocytes and natural killer cells reduced after surgery, probably due to the increased activity of caspase-3. Caspase-3 level was positively correlated with PD-1 expression. Profile of perioperative cytokines and hormones in plasma showed a significantly increased level of interferon-α, as well as various inflammatory cytokines and stress hormones. In ex vivo experiments, administration of anti-PD-1 antibody significantly ameliorated T-cell proliferation and partially reversed the T-cell apoptosis induced by surgical trauma. We provide evidences that surgical trauma can induce immunosuppression through the PD-1/PD-L1 pathway. This pathway could be a target for preventing postoperative cellular immunosuppression.
KeywordsPD-1/PD-L1 Surgery Immunosuppression Lung cancer
Peripheral blood monocyte cells
Programmed death ligand-1
Programmed death ligand-2
Tumor necrosis factor alpha
Funding was received from National Natural Science Foundation of China (NSFC 81471852) and Shanghai Natural Science Foundation (KW 1307, KW142R1407500).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716. doi: 10.1016/S0140-6736(11)61629-2 CrossRefPubMedGoogle Scholar
- 3.Glasner A, Avraham R, Rosenne E et al (2010) Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 184:2449–2457. doi: 10.4049/jimmunol.0903301 CrossRefPubMedGoogle Scholar
- 39.MacFarlane AW IV, Jillab M, Plimack ER et al (2014) PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection. Cancer Immunol Res 2:320–331. doi: 10.1158/2326-6066.CIR-13-0133 PubMedCentralCrossRefPubMedGoogle Scholar